Yahoo Finance Today’s Research Reports on Trending Tickers: Exact Sciences and Immunomedics
NEW YORK, NY / ACCESSWIRE / April 13, 2018 / U.S. markets jumped Thursday as investor's attention shifted from current geopolitical tensions to the upcoming earnings season. Bank stocks were the top gainers in the market as J.P. Morgan Chase, Citigroup and Goldman Sachs all rose more than 2 percent. The Dow Jones Industrial Average spiked 1.21 percent to close at 24,483.05, while the S&P 500 Index jumped 0.83 percent to close at 2,663.99. The Nasdaq Composite Index rose 1.01 percent to close at 7,140.25.
"On one hand, you have earnings that are expected to be strong and the S&P 500 has repeatedly tested its 200-day moving average and held above it. On the other, you have erratic policies and questions over what will happen in Syria, with trade, with the Russia investigation," said Donald Selkin, chief market strategist at Newbridge Securities, according to MarketWatch.
RDI Initiates Coverage on:
Exact Sciences Corp.
https://rdinvesting.com/news/?ticker=EXAS
Immunomedics, Inc.
https://rdinvesting.com/news/?ticker=IMMU
Exact Sciences' stock jumped 7.74% Thursday, to close the day at $45.64. The stock recorded a trading volume of 3,661,146 shares, which was above its three months average volume of 2,912,803 shares. In the last year, Exact Sciences' shares have traded in a range of 23.00 - 63.60. The share price has gained 98.43% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $45.44 is below its 200-day moving average of $50.32. Shares of Exact Sciences have fallen roughly 14.19 percent in the past month and are down 13.13 percent year-to-date.
Access RDI's Exact Sciences Corp. Research Report at:
https://rdinvesting.com/news/?ticker=EXAS
On Thursday, shares of Immunomedics recorded a trading volume of 2,717,757 shares, which was above the three months average volume of 2,216,804 shares. The stock ended the day 6.95% higher at 16.92. The share price has gained 238.40% from its 52-week low with a 52-week trading range of 5.00 - 18.93. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $16.12 is greater than its 200-day moving average of $13.93. Shares of Immunomedics have fallen roughly 2.14 percent in the past month and are up 4.70 percent year-to-date.
Access RDI's Immunomedics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IMMU
Our Actionable Research on Exact Sciences Corp. (NASDAQ :EXAS) and Immunomedics, Inc. (NASDAQ :IMMU) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
